Literature DB >> 19047839

Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.

Bi-Wei Yang1, Ying Liang, Jing-Lin Xia, Hui-Chuan Sun, Lu Wang, Ju-Bo Zhang, Zhao-You Tang, Kang-Da Liu, Jie Chen, Qiong Xue, Jun Chen, Dong-Mei Gao, Wei-Zhong Wu.   

Abstract

OBJECTIVES: To study biological characteristics of stable red fluorescent protein (RFP)-expressing or green fluorescent protein (GFP)-expressing HCCLM3 cell lines and those of their relevant xenograft models in nude mice.
METHODS: HCCLM3, a human hepatocellular carcinoma cell line with high metastatic potential was infected with RFP or GFP full-length cDNA via lentivirus. Stable RFP-expressing or GFP-expressing HCCLM3 cells, namely HCCLM3-R and HCCLM3-G, were subcutaneously injected and two patient-like metastatic models of HCCLM3-R and HCCLM3-G in nude mice were established using surgical orthotopic implantation from subcutaneous tumor tissues. Cell proliferation, karyotype, biomarker expression, tumor growth, and metastasis of HCCLM3-R and HCCLM3-G were analyzed in vitro and in vivo.
RESULTS: RFP and GFP genes were integrated in genomic DNA of HCCLM3. HCCLM3-R and HCCLM3-G expressed red and green fluorescence, stable and intense, 300 days after 60 consecutive passages, and also positively expressed CK8+, P16+, AFP+ and negatively expressed HBsAg-. Their biomarker expression and karyotype were found to be similar to those of the parental HCCLM3, and their tumorigenesis occurred in 10 nude mice without exception after a subcutaneous injection and did the same in 20 nude mice after an orthotopic implantation. The results showed that the rate of spontaneous metastasis to the liver and lung and peritoneal seeding was 100, 100, and 90%, respectively.
CONCLUSION: Stable fluorescent protein-expressing HCCLM3-R and HCCLM3-G xenografts in nude mice could be of two useful models for studying mechanisms of hepatocellular carcinoma growth and metastasis in real time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047839     DOI: 10.1097/MEG.0b013e3283050a67

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  25 in total

1.  Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.

Authors:  Peng-Yuan Zhuang; Ju-Bo Zhang; Wei Zhang; Xiao-Dong Zhu; Ying Liang; Hua-Xiang Xu; Yu-Quan Xiong; Ling-Qun Kong; Lu Wang; Wei-Zhong Wu; Zhao-You Tang; Lun-Xiu Qin; Hui-Chuan Sun
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

2.  Establishment of an insufficient radiofrequency ablation orthotopic nude mouse model of hepatocellular carcinoma to study the invasiveness and metastatic potential of residual cancer.

Authors:  Ning Zhang; Hua Zhu; Ye-Hao Dong; Lu Wang
Journal:  Oncol Lett       Date:  2019-07-02       Impact factor: 2.967

3.  Establishment of a malignant pleural effusion mouse model with lewis lung carcinoma cell lines expressing enhanced green fluorescent protein.

Authors:  Xingqun Ma; Yu Sun; Shouju Wang; Zhijian Yang; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2012-09

4.  PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.

Authors:  Bo-Yi Liao; Zheng Wang; Jie Hu; Wei-Feng Liu; Zao-Zhuo Shen; Xin Zhang; Lei Yu; Jia Fan; Jian Zhou
Journal:  Tumour Biol       Date:  2015-09-28

5.  Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Authors:  Cun Wang; Dongmei Gao; Kun Guo; Xiaonan Kang; Kai Jiang; Chun Sun; Yan Li; Lu Sun; Hong Shu; Guangzhi Jin; Haiyan Sun; Weizhong Wu; Yinkun Liu
Journal:  BMC Cancer       Date:  2012-05-04       Impact factor: 4.430

6.  Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.

Authors:  Peng-Yuan Zhuang; Jun Shen; Xiao-Dong Zhu; Ju-Bo Zhang; Zhao-You Tang; Lun-Xiu Qin; Hui-Chuan Sun
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

7.  After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.

Authors:  Jian Kong; Lingqun Kong; Jinge Kong; Shan Ke; Jun Gao; Xuemei Ding; Lemin Zheng; Huichuan Sun; Wenbing Sun
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

8.  Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.

Authors:  Wen-Quan Wang; Liang Liu; Hui-Chuan Sun; Yan-Ling Fu; Hua-Xiang Xu; Zong-Tao Chai; Qiang-Bo Zhang; Ling-Qun Kong; Xiao-Dong Zhu; Lu Lu; Zheng-Gang Ren; Zhao-You Tang
Journal:  J Hematol Oncol       Date:  2012-11-08       Impact factor: 17.388

9.  Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness.

Authors:  Qing-An Jia; Zheng-Gang Ren; Yang Bu; Zhi-Ming Wang; Qiang-Bo Zhang; Lei Liang; Xue-Mei Jiang; Quan-Bao Zhang; Zhao-You Tang
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

10.  miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.

Authors:  Zhong-Hua Tao; Jin-Liang Wan; Ling-Yao Zeng; Lu Xie; Hui-Chuan Sun; Lun-Xiu Qin; Lu Wang; Jian Zhou; Zheng-Gang Ren; Yi-Xue Li; Jia Fan; Wei-Zhong Wu
Journal:  J Exp Med       Date:  2013-03-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.